Time to go All-In on Celsion?
Celsion (CLSN) is a great story stock. It recently announced their Phase III trial results for liver cancer will be released by the end of January 2013. This will be a top-line release of a multinational, double-blind, placebo-controlled study of primary liver cancer. The results could make or break the company as its future pipeline is dependent on ThermoDox succeeding.
This upcoming catalyst is likely to have a huge impact on the company's valuation. The company has a current market cap of $287 million, but this will likely be drastically different by the end of the month. The CEO of Celsion has stated that this liver cancer treatment will have the potential to generate yearly revenues of $1 billion.
Mastery Bottom Line
Look for a good entry point before betting the farm on CLSN. Shares could dip down to touch the 50 day MA due to some investors not wanting to risk holding through the FDA results. A $7 - $7.50 share price would provide a great buying opportunity.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Best Reaction Yet: "Yellen Speech A Whole Lot Of Nothing" | ZeroHedge
- Herbalife Surges After Icahn Denies WSJ Selling Report, Says He Bought Another 2.3 Million Shares | ZeroHedge
- Consumer Confidence Slumps As Inflation Expectations Crash To All-Time Lows | ZeroHedge
- Mylan Caves, Announces EpiPen Cost Cuts Up To 50% | ZeroHedge
- Dakota Access Pipeline Tensions Grow Increasingly Hostile As Officials Cut Off Water Supply, Arrest Dozens | ZeroHedge
- In Surprising Twist, Ackman Named As Potential Buyer Of Icahn Herbalife Stake | ZeroHedge
- J-Holed: Stocks Slide After "Good" Yellen, "Bad" Powell, & "Ugly" Fischer | ZeroHedge
The most relevant financial news and articles from the Internets
- Volkswagen reaches deal to compensate U.S. dealers:... | Business Insider
- THE MOBILE APP-INSTALL AD REPORT: Spending forecasts, performance and price trends, and... | Business Insider
- 5 countries to visit that you couldn't travel to before | Business Insider
- 32 things you should never say to your boss | Business Insider
- THE... | Business Insider
- Tom Hiddleston's Instagram has been hacked, just after he got it | Business Insider
- In Iran, anyone can sell their kidney for thousands of... | Business Insider